Retraction

Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1002/jcp.30897
Additional Notes:

see also: https://pubpeer.com/publications/3664D4787D97F2A2B5736FD499B6F3

Citations (5)

5
Total Citations
4
Post-Retraction
(80.0%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
3 Within 1 year
1 After 2+ years
760 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation
Yan Ye, Xiuli Zhang, Chenyi Wang et al. (12 authors)
Cancer Cell International Open Access
Published: Nov 2024
1 citation
760 days after retraction
Cell-free plasma miRNAs analysis for low invasive lung cancer diagnostics
Maria Konoshenko, Pavel P. Laktionov, Yu. A. Lancuhaj et al. (6 authors)
Advances in molecular oncology Open Access
Published: Jul 2023
263 days after retraction
Overexpression of DAPK1 and Beclin1 under oxygen and glucose deprivation conditions promotes excessive autophagy and apoptosis in A549 cells
Linlin Wu, Wenxue Sun, Dehua Liao et al. (7 authors)
MedComm – Oncology Open Access
Published: Apr 2023
2 citations
188 days after retraction
Diverse Functions of MiR-425 in Human Cancer
Zhichao Wang, Wenjie Xie, Hongzai Guan
DNA and Cell Biology
Published: Feb 2023
4 citations
119 days after retraction